Review: doxorubicin delivery systems based on chitosan for cancer therapy.
about
A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNAProbing the binding sites of antibiotic drugs doxorubicin and N-(trifluoroacetyl) doxorubicin with human and bovine serum albuminsAnthracycline Drugs on Modified Surface of Quercetin-Loaded Polymer Nanoparticles: A Dual Drug Delivery Model for Cancer TreatmentDoxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking.Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumabEnhancing the Effects of Low Dose Doxorubicin Treatment by the Radiation in T47D and SKBR3 Breast Cancer Cells.Possibilities to increase the effectiveness of doxorubicin in cancer cells killing.Microbial natural products: molecular blueprints for antitumor drugs.Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?Molecular aspects on adriamycin interaction with hmga1 regulatory region and its inhibitory effect on HMGA1 expression in human cervical cancer.Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis.Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.The effect of anticancer drugs on seven cell lines monitored by FTIR spectroscopy.The FTIR spectrum of prostate cancer cells allows the classification of anticancer drugs according to their mode of action.The effectiveness of oracin in enhancing the cytotoxicity of doxorubicin through the inhibition of doxorubicin deactivation in breast cancer MCF7 cells.Enhanced dissolution and oral bioavailability of tanshinone IIA base by solid dispersion system with low-molecular-weight chitosan.Chitosan and its derivatives as vehicles for drug delivery.Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.Label-free imaging of polymeric nanomedicines using coherent anti-stokes Raman scattering microscopyIn vivo pharmacokinetic features and biodistribution of star and rod shaped gold nanoparticles by multispectral optoacoustic tomography
P2860
Q28394647-E1BCD819-6059-4DA4-B470-114559D04043Q28482550-31B15445-06F1-4E36-B6AF-B3BF5B5A00BCQ28552231-67E24B20-A641-4B7A-B6AD-A253C933AE25Q30472420-CCE50BA6-0751-4C6F-962F-DB91B386F739Q35234716-46F93051-99EF-4DDE-846B-63F962DB7001Q36998118-93F9A090-06E7-4DFC-ABD4-C884C963832BQ37937579-63BEA2C4-D1FD-4D5C-834C-E13784102B77Q38133765-07EFE6D2-C059-4729-B12E-70E9CDC73EE6Q38150426-CD05B422-A99D-4D53-90BA-C48A7CB7DFE8Q38862908-CC3F68B1-3775-49F1-93A4-D155954892D6Q38957716-E51BB0E2-3ECC-4905-A3CD-C7D636CD266AQ39231810-7375516C-FCD2-4D38-9A69-E50358E73A3CQ39335866-695D652F-51E7-42F5-AB25-A742949ECEA1Q39605411-23338854-3F34-4509-B9FC-BA4938F7EAE7Q39669089-926140FC-4B95-47A9-8F14-CF92ECFDC323Q47236613-052AB768-CBAB-4650-9791-7F5ABCB3662FQ50073720-01D48D2F-F1E2-4BB6-9C03-9369BAAAAEA2Q50638687-ACD8260B-34EE-40A1-BA04-F1C1059DECF5Q57610436-C84B82D4-7F3B-4140-95AF-877F8F1E3D45Q58068745-E98918B7-40E3-4648-8B11-24E6EE57CF48
P2860
Review: doxorubicin delivery systems based on chitosan for cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Review: doxorubicin delivery systems based on chitosan for cancer therapy.
@en
Review: doxorubicin delivery systems based on chitosan for cancer therapy.
@nl
type
label
Review: doxorubicin delivery systems based on chitosan for cancer therapy.
@en
Review: doxorubicin delivery systems based on chitosan for cancer therapy.
@nl
prefLabel
Review: doxorubicin delivery systems based on chitosan for cancer therapy.
@en
Review: doxorubicin delivery systems based on chitosan for cancer therapy.
@nl
P2860
P356
P1476
Review: doxorubicin delivery systems based on chitosan for cancer therapy
@en
P2093
Crispin R Dass
Mei Lin Tan
P2860
P304
P356
10.1211/JPP.61.02.0001
P577
2009-02-01T00:00:00Z